We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Epix Plans To Appeal FDA Drug Decision

Law360 (December 15, 2006, 12:00 AM EST) -- EPIX Pharmaceuticals Inc. said Friday that it plans to appeal a decision by the U.S. Food and Drug Administration denying approval of blood-pool imaging agent Vasovist.

The FDA’s Office of New...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.